Laura Rosen

Company: Acumen Pharmaceuticals

Job title: Senior Vice President - Clinical Development

Seminars:

9:00 P-tau217: Clinical Promise, Regulatory Hurdles & the Path to Surrogate Endpoint Status 9:00 am

Highlighted by the recent approval of the first in vivo blood test for Alzheimer’s Disease, advancements in new technologies to measure p-tau217 are at an all-time-high. Join this session for an inside look on how p-tau217 is setting the gold standard in AD diagnostics, exploring its scientific evolution, clinical impact, and regulatory breakthrough, offering a…Read more

day: Pre-Conference Workshop Day

10:30 Roundtable: Smarter Stratification With the Right Patients for the Right Trials & the Right Trials for the Right Patients 10:30 am

Biomarkers for stratifying patient subgroups in heterogeneous diseases (e.g., MS, AD, PD, ALS) Distinguishing predictive, diagnostic, and pharmacodynamic biomarkers Leveraging biomarkers for adaptive trial designs Incorporating polygenic scores into stratification models (with genomic context) • Personalized medicine in neuroscience: myth or future? Read more

day: Conference Day 2